Israel Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israeli-based biotech companies. The firm invests exclusively in Biotech companies developing drugs at or near clinical stages.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions